Ziac vs. Amlodipine besylate; olmesartan medoxomil: side effect and effectiveness comparison - a phase IV clinical study

Summary:

We compare the side effects and drug effectiveness of Ziac and Amlodipine besylate; olmesartan medoxomil. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 10,875 people who take Ziac and Amlodipine besylate; olmesartan medoxomil, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

10,875 people who take Ziac and Amlodipine besylate; olmesartan medoxomil are studied.


What is Ziac?

Ziac has active ingredients of bisoprolol fumarate; hydrochlorothiazide. It is often used in high blood pressure. eHealthMe is studying from 4,389 Ziac users for its effectiveness, alternative drugs and more.

What is Amlodipine besylate; olmesartan medoxomil?

Amlodipine besylate; olmesartan medoxomil has active ingredients of amlodipine besylate; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 6 Amlodipine besylate; olmesartan medoxomil users for its effectiveness, alternative drugs and more.

Number of reports submitted per year:

Ziac vs Amlodipine besylate; olmesartan medoxomil drug comparison reports.

Drugs being compared in this study:

  • Ziac (bisoprolol fumarate; hydrochlorothiazide)
  • Amlodipine Besylate; Olmesartan Medoxomil (amlodipine besylate; olmesartan medoxomil)

Most common side effects of the drugs, overall:

Click here to view

Most common side effects of the drugs, in long term (1+ years) use:

Click here to view

Drug effectiveness:

Ziac:
  • not at all: 1.06 %
  • somewhat: 15.19 %
  • moderate: 32.86 %
  • high: 37.46 %
  • very high: 13.43 %
Amlodipine Besylate; Olmesartan Medoxomil:
  • not at all: 0.53 %
  • somewhat: 15.51 %
  • moderate: 32.09 %
  • high: 39.57 %
  • very high: 12.3 %

Want to compare Ziac with Amlodipine besylate; olmesartan medoxomil?

Personalize this study to your gender and age (0-99+).

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of:

Common Ziac side effects:

How the study uses the data?

The study is based on bisoprolol fumarate; hydrochlorothiazide and amlodipine besylate; olmesartan medoxomil (the active ingredients of Ziac and Amlodipine besylate; olmesartan medoxomil, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: